← Evidence map

ArticleAdvances in therapy2026

Assessing the Value of PureWick™ for Female Urinary Incontinence in Non-Acute Settings: Multi-Country Cost-Effectiveness and Budget Impact Analyses.

Carla Rognoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41954862